BioSpace News Archive

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the initiation of the CALYPSO program to study the role that human genetic variations play in SARS-CoV-2 (“COVID-19") infection and disease progression.

New treatments designed to prevent cancer from developing, based on changing the microenvironment in which cancer cells evolve, could be both feasible and effective.

The Mylan N.V. (NASDAQ: MYL) Board of Directors today announced the appointment of Robert J. Coury , previously chairman of the Mylan Board, to the position of executive chairman of Mylan. Given the unprecedented current operating environment due to the COVID-19 pandemic, the extensive ongoing activity

The home care services market is anticipated to record a growth rate of 9.9% and reach a market value of US$ 194,649.1 Mn by the end of 2018. Nursing care will continue to account for the leading market revenue share by service type, accounting for 36.8% share in 2018. Key insights on the home care services market have been presented in a new study by Persistence Market Research.

Recent advancements in ostomy care accessories have transformed them into small and portable wearable devices, improving standards of clinical care. For instance, Ostom-iAlert Sensor, a clipped device from 11 Health Technologies Limited, uses a flexible sensor that provides a signal when the bag is full, through a notification on a smartphone.

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco -based company focused on in vitro diagnostics, today announced that they have entered into a commercial supply and collaboration agreement. Under the agreement, Accelerate Diagnostics will distribute the BioCheck MS-FAST, a fully-automat

Persistence Market Research delivers key insights on the global scoliosis management market in its upcoming outlook titled “Scoliosis Management Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2028”. In terms of value, the global scoliosis management market is projected to register a CAGR of 3.6% during the forecast period due to various factors, regarding which the report offers vital insights in detail.

Patients suffering from critical lifestyle diseases are benefited the most and manufacturers are integrating technology to build cutting-edge products that can meet the increasing demand from the healthcare industry. Wearable injectors with monitoring devices to help doctors track patient records are being developed to help reduce the number of hospital visits.

Rising prevalence of obesity, growing geriatric population with higher risk of heart diseases, and rapid technological advancements to detect arrhythmia are critical factors for the growth of the transseptal access systems market. Introduction of innovative technologies such as left atrial appendage occlusion therapy is benefitting patients who are at high risk of strokes due to non-valvular atrial fibrillation (AF).

Quansys Biosciences in Logan, Utah , released their SARS-CoV-2 Human IgG(4-plex) enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of SARS-CoV-2 reactive IgG class antibodies in human serum and plasma. SARS-CoV-2 is the novel coronavirus responsible for COVID-19.